For manufacturers & payers

If you build joint implants,
your pre-surgical demand starts here.

arthritisrisk.com is the consumer-direct funnel for the 32M Americans with knee/hip OA — the cohort that becomes your TKA, THA, and biologic patients. We score risk, attest with a licensed physician, and route qualified candidates into the ACCESS MSK pathway. Co-build with us instead of building it yourself.

The funnel, in numbers

32M
US adults with OA
$180/yr
ACCESS MSK OAP per beneficiary
10 yr
CMS program duration
100%
Physician-attested via altru.care

Every risk score on arthritisrisk.com is reviewed and signed by a board-certified physician (Josh Emdur DO, via altru.care). Every attestation is hashcare-receipted — cryptographically timestamped, audit-defensible, portable. This isn't an SEO content site; it's an attested clinical funnel running on the SolvingHealth network.

ACCESS MSK · CMS application window closes May 15, 2026. Cohort 1 starts July 5, 2026 — 10-year program. Partners who co-build with arthritisrisk before May 15 share the funnel from cohort 1. After May 15, you're building from scratch on a 12-month delay.

What partnership unlocks

Who this is for

Orthopedic device manufacturers — DePuy Synthes, Stryker, Zimmer Biomet, Smith+Nephew, Conformis. Your TKA/THA implants need pre-surgical demand at scale. arthritisrisk is the funnel.

Rheumatology pharma — DMARD and biologic manufacturers (AbbVie, Bristol-Myers, Lilly, Amgen, Pfizer, Novartis, Genentech). Patient activation for inflammatory arthritis pathways before surgical eligibility.

Health-system orthopedic service lines running CJR-X, BPCI-Advanced, or commercial bundled-care contracts. Pre-surgical risk-stratified panel.

Medicare Advantage plans with MSK risk-adjustment exposure — partner via the SolvingHealth attestation feed (Vimty/TrueField).

Set up an intro call before May 15.

30 min. We walk through the ACCESS MSK timeline, the funnel mechanics, and where co-building fits your patient-acquisition stack.

Request a partner intro →